Prophylactic treatment for acneiform rash caused by EGFR inhibitors: Prospective randomized double-blind trial comparing daily topical chloramphenicol 3% plus prednisolone 0.5% vs chloramphenicol 3% vs aqua cream.

Salomon M. Stemmer,Hadas Prag-Naveh,Ayelet Ollech,Aron Popovitzer,Ofer Purim,Dov Flex,Yael Leshem,Batya Davidovici,Olga Ulitsky,Baruch Brenner,Irit Ben Aharon,Nir Peled,Michael David,Iris Amitay-Laish

Prophylactic treatment for acneiform rash caused by EGFR inhibitors: Prospective randomized double-blind trial comparing daily topical chloramphenicol 3% plus prednisolone 0.5% vs chloramphenicol 3% vs aqua cream.

2018

Salomon M. Stemmer
Hadas Prag-Naveh
Ayelet Ollech
Aron Popovitzer
Ofer Purim
Dov Flex
Yael Leshem
Batya Davidovici
Olga Ulitsky
Baruch Brenner
Irit Ben Aharon
Nir Peled
Michael David
Iris Amitay-Laish

10092Background: Epidermal growth factor receptor inhibitors (EGFR-I), which are indicated for various tumor types, are associated with acneiform rash on the face/torso in approximately 90% of pati...

Keywords:

Rash
Prednisolone
EGFR inhibitors
Anesthesia
Physical therapy
Medicine
Chloramphenicol
acneiform rash
Dermatology
Epidermal Growth Factor Receptor Inhibitors
prophylactic treatment
double blind
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations